调情 发表于 2025-3-23 09:53:42

http://reply.papertrans.cn/1/5/437/437-11.png

完成才会征服 发表于 2025-3-23 16:54:07

Submitted on: 17 December 2007.
Revised on: 09 February 2008.
Accepted on: 13 March 2008.

___________________ACTA PHARMACEUTICA---SCIENDO

易达到 发表于 2025-3-23 22:02:13

Submitted on: 02 December 2020.
Revised on: 06 March 2021.
Accepted on: 23 April 2021.

___________________ACTA PHARMACEUTICA---SCIENDO

Adrenaline 发表于 2025-3-24 02:00:38

Submitted on: 30 July 2017.
Revised on: 22 November 2017.
Accepted on: 02 January 2018.

___________________ACTA PHARMACEUTICA---SCIENDO

Gobble 发表于 2025-3-24 04:17:11

Submitted on: 12 January 2010.
Revised on: 18 April 2010.
Accepted on: 22 May 2010.

___________________ACTA PHARMACEUTICA---SCIENDO

Explosive 发表于 2025-3-24 06:42:18

http://reply.papertrans.cn/1/5/437/437-16.png

capillaries 发表于 2025-3-24 13:11:19

http://reply.papertrans.cn/1/5/437/437-17.png

Type-1-Diabetes 发表于 2025-3-24 15:44:15

Submitted on: 12 November 2005.
Revised on: 04 December 2005.
Accepted on: 24 January 2006.

___________________ACTA PHARMACEUTICA---SCIENDO

Substance 发表于 2025-3-24 21:42:56

http://reply.papertrans.cn/1/5/437/437-19.png

冲击力 发表于 2025-3-25 01:42:40

http://reply.papertrans.cn/1/5/437/437-20.png
页: 1 [2] 3 4
查看完整版本: SCIE期刊ACTA PHARMACEUTICA 2024/2025影响因子:2.194 (ACTA PHARMACEUT) (1330-0075). (PHARMACOLOGY & PHARMACY)(药理学与药学)Science Ci